On top of that, the combination of AS-IV and ginsenoside Rg1 augments the protective outcomes towards cerebral ischemic injuries by using antiapoptotic and anti-inflammatory consequences. The underlying mechanism is probably associated with the inhibition of NF-κB and JAK1/STAT1 signaling path